Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient

Mult Scler. 2015 May;21(6):795-6. doi: 10.1177/1352458514555788. Epub 2014 Nov 28.

¹ 1st Department of Neurology, Aeginition Hospital, School of Medicine, Kapodistrian University of Athens, Athens, Greece kmwartem@yahoo.com.
² Department of Neurology, NIMTS Hospital, Athens, Greece.
³ Department of Hematology, NIMTS Hospital, Athens, Greece.
⁴ Hellenic Centre for Diseases Control and Prevention, Ministry of Health, Athens, Greece.
⁵ 1st Department of Neurology, Aeginition Hospital, School of Medicine, Kapodistrian University of Athens, Athens, Greece.

No abstract available

Keywords: Visceral; fingolimod; infection; leishmaniasis; multiple sclerosis; side-effect.

Publication types